Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 5409, 2020 03 25.
Artigo em Inglês | MEDLINE | ID: mdl-32214116

RESUMO

Nucleic acid amplification-based diagnostics is known as one of the molecular diagnostic systems that allows higher sensitive detection of pathogens than test methods such as immunoassay. However, it has not been widely used because it is complicated to use and takes a long time to generate results. On the other hand, development of fully automated molecular diagnostic systems has been growing around the world as demand for such systems from physicians and laboratory technicians has increased. To meet this demand, we have developed the "Simprova" fully automated molecular diagnostic system, which takes advantage of LAMP (Loop-mediated Isothermal Amplification), a method Eiken Chemical Co., Ltd. invented. Simprova comprises a master unit that controls the entire system and a test unit that extracts and purifies nucleic acid from samples (pretreatment), and uses the LAMP method to detect and amplify nucleic acid. Users can obtain test results automatically by simply installing a pretreatment cartridge, a multi-well testing chip and the sample in the test unit. The multi-well testing chip has 25 reaction wells connected by channels and enables simultaneous testing of multiple targets with one sample. Turnaround time for one test is approximately 30 minutes. Since a conventional extraction and purification method using magnetic-bead separation is used for the pretreatment, nucleic acid can be extracted from serum, plasma, whole blood, urine, and sputum, for example. In addition, the system can perform random-access testing by connecting four test units to the master unit to realize near-the-patient testing. Simprova is therefore a robust and useful system for a wide variety of applications.

2.
Biosci Biotechnol Biochem ; 81(6): 1227-1234, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28290772

RESUMO

We screened for factors involved in the cellulose-responsive induction of cellulose biomass-degrading enzyme genes from approximately 12,000 Aspergillus aculeatus T-DNA insertion mutants harboring a transcriptional fusion between the FIII-avicelase gene (cbhI) promoter and the orotidine 5'-monophosphate decarboxylase gene. Analysis of 5-fluoroorodic acid (5-FOA) sensitivity, cellulose utilization, and cbhI expression of the mutants revealed that a mutant harboring T-DNA at the dipeptidyl peptidase IV (dppIV) locus had acquired 5-FOA resistance and was deficient in cellulose utilization and cbhI expression. The deletion of dppIV resulted in a significant reduction in the cellulose-responsive expression of both cbhI as well as genes controlled by XlnR-independent and XlnR-dependent signaling pathways at an early phase in A. aculeatus. In contrast, the dppIV deletion did not affect the xylose-responsive expression of genes under the control of XlnR. These results demonstrate that DppIV participates in cellulose-responsive induction in A. aculeatus.


Assuntos
Aspergillus/genética , Celulases/genética , Celulose/metabolismo , Dipeptidil Peptidase 4/genética , Proteínas Fúngicas/genética , Regulação Fúngica da Expressão Gênica , Orotidina-5'-Fosfato Descarboxilase/genética , Aspergillus/efeitos dos fármacos , Aspergillus/enzimologia , Celulases/metabolismo , Celulose/farmacologia , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Dipeptidil Peptidase 4/agonistas , Dipeptidil Peptidase 4/metabolismo , Proteínas Fúngicas/metabolismo , Deleção de Genes , Mutagênese Insercional , Ácido Orótico/análogos & derivados , Ácido Orótico/metabolismo , Ácido Orótico/farmacologia , Orotidina-5'-Fosfato Descarboxilase/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Transdução de Sinais , Xilose/metabolismo , Xilose/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...